Objectives
Disruptive Mood Dysregulation Disorder: A Review Of The Literature
After participating in this educational activity, attendees should be able to:
1. Define DSM 5 criteria for Disruptive Mood Dysregulation Disorder
2. Explain why DMDD was introduced into the DSM 5 in 2012
3. Discuss why the diagnosis is controversial
Literature review for Recommendations for Treating Chronic Persistent Irritability or DMDD
After participating in this educational activity, attendees should be able to:
1. Discuss the paucity of literature despite the prevalence of irritability in the community
2. Describe how we conducted the literature review via use of pub med, inclusion, and exclusion criteria
3. Identify articles that address chronic irritability and DMDD and what treatment recommendations are available
Faculty
Sajel Shah, MD
PGY-3 Psychiatry Resident
Kerry Sheahan, DO
PGY-3 Psychiatry Resident
Faculty Disclosure
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
None of the other members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 APA American Psychological AssociationBaystate Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Baystate Health maintains responsibility for this program and its content.
- 1.00 BCIPE Instructional Hours
- 1.00 NBCCBaystate Health is an NBCC Approved Continuing Education Provider (ACEP™) and may offer NBCC approved clock hours for events that meet NBC requirements. The ACEP solely responsible for all aspects of the program.